P2.16-02 Pembrolizumab, Lenvatinib and Chemotherapy Combination in First Line Extensive-Stage Small Cell Lung Cancer: PEERS Phase 2 Trial
Reguart Aransay, N., Victoria, I., Martí, J.L., Carcereny, E., Arasanz, H., Dómine, M., Fernández, N., Sala, M.A., Marín, E., Sanfeliu, E., Arcocha, A., Martinez, D., Reyes, R., Navarro, A., Barba, A., García-Campelo, R., Giner, J., Blasco, A., Sais, E., Gutiérrez, V., Marsé, R., Martín, P., Zugazagoita, J., Salinas, B., Cobo, S., Provencio, M.
Published in Journal of thoracic oncology (01.11.2023)
Published in Journal of thoracic oncology (01.11.2023)
Get full text
Journal Article